Study to Evaluate the Efficacy and Safety of VGR-R01 Gene Therapy in Patients With Bietti Crystalline Dystrophy
Clinical trial NCT06699108 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06699108
- Sponsor
- Shanghai Vitalgen BioPharma Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-13
- Primary completion
- 2026-12-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.